Clee Medical honored with the W.A De Vigier award 2025, one of Switzlerand’s most prestigious prizes for entrepreneurs and start ups. 🎉
This recognition fuels our mission to enable safer, more precise access to the brain by combining novel real-time ultra-high-resolution imaging with AI-guided navigation to treat neurological conditions ranging from neurostimulation, epilepsy, cancer, and beyond.
This milestone wouldn’t have been possible without the incredible support from our partners, advisors, investors, and early clinical collaborations. A heartfelt thank you to everyone who believes in our vision and pushes us forward every day.
A special thanks to the W.A. De Vigier Stiftung for believing in deeptech innovation and to our amazing fellow finalists.
Onwards as we forge a new era of highly targeted neuro therapies!